EMAIL THIS PAGE TO A FRIEND

British journal of cancer

Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells.


PMID 25137017

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is among the most aggressive human malignancies with an overall 5-year survival rate of <5%. Despite significant advances in treatment of the disease during the past decade, the median survival rate (∼6 months) has hardly improved, warranting the need to identify novel targets for therapeutic approaches. Quantitative real time PCR, western blot analyses and immunohistochemical staining of tissue microarrays were used to analyse the expression of TTK gene in primary PDAC tissues and cell lines. To inhibit TTK kinase expression in a variety of pancreatic cancer cell lines, RNA interference was used. Functional roles of this kinase in the context of PDAC were studied using cell proliferation, viability and anchorage-independent growth assays. Western blotting, fluorescence-activated cell sorting analyses and fluorescence microscopy were used to gain mechanistic insight into the functional effects. We show that the dual specificity kinase TTK (also known as Mps1), is strongly overexpressed in human PDAC. Functionally, cell proliferation was significantly attenuated following TTK knockdown, whereas apoptosis and necrosis rates were significantly increased. In addition, anchorage-independent growth, a hallmark of malignant transformation and metastatic potential, was strongly impaired in the absence of TTK gene function. Interestingly, immortalised normal pancreatic hTERT-HPNE cells were not affected by loss of TTK function. Mechanistically, these effects in cancer cells were associated with increased formation of micronuclei, suggesting that loss of TTK function in pancreatic cancer cells results in chromosomal instability and mitotic catastrophe. Taken together, our data show that TTK function is critical for growth and proliferation of pancreatic cancer cells, thus establishing this kinase as an interesting new target for novel therapeutic approaches in combating this malignancy.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

PHR1072
2-Propanol, Pharmaceutical Secondary Standard; Certified Reference Material
C3H8O
91237
2-Propanol, analytical standard
C3H8O
1570428
2-Propanol, United States Pharmacopeia (USP) Reference Standard
C3H8O
SAB2501669
Anti-CASP3 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB4503291
Anti-CASP3 antibody produced in rabbit, affinity isolated antibody
AV00021
Anti-CASP3 antibody produced in rabbit, IgG fraction of antiserum
HPA002643
Anti-CASP3 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
C9598
Anti-Caspase 3 antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
C8831
Anti-Cyclin B1 antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB4503501
Anti-Cyclin B1 antibody produced in rabbit, affinity isolated antibody
SAB4503502
Anti-Cyclin B1 antibody produced in rabbit, affinity isolated antibody
05-682
Anti-Mps1 Antibody, NT, clone 3-472-1, clone 3-472-1, Upstate®, from mouse
SAB4500487
Anti-PARP (Cleaved-Asp214) antibody produced in rabbit, affinity isolated antibody
SAB4500488
Anti-PARP (Cleaved-Gly215) antibody produced in rabbit, affinity isolated antibody
P7605
Anti-PARP antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA045168
Anti-PARP1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV33754
Anti-PARP1 antibody produced in rabbit, IgG fraction of antiserum
SAB4504363
Anti-phospho-Chk1 (pSer280) antibody produced in rabbit, affinity isolated antibody
SAB4504025
Anti-phospho-Chk1 (pSer296) antibody produced in rabbit, affinity isolated antibody
SAB4504147
Anti-phospho-Chk1 (pSer301) antibody produced in rabbit, affinity isolated antibody
SAB4504364
Anti-phospho-Chk1 (pSer317) antibody produced in rabbit, affinity isolated antibody
SAB4504365
Anti-phospho-Chk1 (pSer345) antibody produced in rabbit, affinity isolated antibody
SRP3027 EGF human, Animal-component free, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
E5036
Epidermal Growth Factor, human, animal component free, EGF, recombinant, expressed in Escherichia coli, >97% (SDS-PAGE)
WH0000836M2
Monoclonal Anti-CASP3 antibody produced in mouse, clone 4D3, purified immunoglobulin, buffered aqueous solution
C5737 Monoclonal Anti-Caspase 3 antibody produced in mouse, clone 84803.111, purified immunoglobulin, lyophilized powder
WH0000891M1
Monoclonal Anti-CCNB1 antibody produced in mouse, clone 1C8, purified immunoglobulin, buffered aqueous solution
SAB5300329 Monoclonal Anti-CCNB1 antibody produced in mouse, clone 1B10, ascites fluid
SAB5300330
Monoclonal Anti-CCNB1 antibody produced in mouse, clone 5G6, ascites fluid
P248 Monoclonal Anti-PARP antibody produced in mouse, clone C-2-10, ascites fluid